Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
UBS
Healthtrust
Chubb
Medtronic
Cantor Fitzgerald
Boehringer Ingelheim
Novartis
Colorcon

Generated: January 18, 2018

DrugPatentWatch Database Preview

Griseofulvin, ultramicrosize - Generic Drug Details

« Back to Dashboard

What are the generic sources for griseofulvin, ultramicrosize and what is the scope of griseofulvin, ultramicrosize freedom to operate?

Griseofulvin, ultramicrosize
is the generic ingredient in three branded drugs marketed by Valeant Pharms Inc, Impax Labs Inc, and Sigmapharm Labs Llc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, ultramicrosize. Six suppliers are listed for this compound.
Pharmacology for griseofulvin, ultramicrosize

US Patents and Regulatory Information for griseofulvin, ultramicrosize

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc GRISEOFULVIN, ULTRAMICROSIZE griseofulvin, ultramicrosize TABLET;ORAL 204371-001 Jan 9, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc GRISEOFULVIN, ULTRAMICROSIZE griseofulvin, ultramicrosize TABLET;ORAL 204371-002 Jan 9, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms Inc GRIS-PEG griseofulvin, ultramicrosize TABLET;ORAL 050475-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms Inc GRIS-PEG griseofulvin, ultramicrosize TABLET;ORAL 050475-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc GRISEOFULVIN,ULTRAMICROSIZE griseofulvin, ultramicrosize TABLET;ORAL 202545-002 Oct 22, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc GRISEOFULVIN,ULTRAMICROSIZE griseofulvin, ultramicrosize TABLET;ORAL 202545-001 Oct 22, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
Teva
Moodys
Healthtrust
Fuji
Daiichi Sankyo
Argus Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot